614
Participants
Start Date
May 31, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
February 29, 2012
Brisdelle (paroxetine mesylate)
Subjects will be randomized to receive either Brisdelle (paroxetine mesylate) Capsules 7.5 mg or placebo in a 1:1 ratio, administered once daily at bedtime beginning on Day 1 and continuing up to Day 84
Placebo capsules
Subjects will be randomized to receive either Brisdelle (paroxetine mesylate) Capsules 7.5 mg or placebo in a 1:1 ratio, administered once daily at bedtime beginning on Day 1 and continuing up to Day 84
NY Center for Women's Health Research, New York
Susan L Floyd, MD, PC, Wexford
Clinical Trials Research Services, LLC, Pittsburgh
The Clinical Trial Center, LLC, Jenkintown
Philadelphia Clinical Research, Philadelphia
James A. Simon, MD, PC, Washington D.C.
Virginia Women's Center, Richmond
National Clinical Research, Inc., Richmond
Tidewater Clinical Research, Inc, Virginia Beach
Clinical Trials of America, Inc., Winston-Salem
Hawthorne Medical Research, Inc., Winston-Salem
Wake Research Associates, Raleigh
Coastal Carolina Research Center, Mt. Pleasant
Soapstone Center for Clinical Research, Decatur
Mount Vernon Clinical Research, LLC, Sandy Springs
University of Florida College of Medicine - Jacksonville Southside Women's Health, Jacksonville
DBC Research, Deerfield Beach
Health Awareness, Inc., Jupiter
Tampa Bay Medical Research, Inc., Clearwater
Clinical Physiology Associates, Fort Myers
Meridien Research, Bradenton
Meridien Research, Brooksville
Suncoast Clinical Research, Inc., New Port Richey
Suncoast Clinical Research, Inc., Palm Harbor
Wilmax Clinical Research, Mobile
Access Clinical Trials, Inc., Nashville
Chattanooga Medical Research, LLC, Chattanooga
Bluegrass Clinical Research, Inc., Louisville
Columbus Center for Women's Health Research, Columbus
Complete Healthcare for Women, Columbus
Rapid Medical Research, Inc., Cleveland
University Hospitals of Cleveland Landerbrook Health Center, Mayfield Heights
HWC Women's Research Center, Englewood
ClinSite, LLC, Ann Arbor
Hutzel Womens Health Research, Detroit
Professional Clinical Research, Benzonia
Professional Clinical Research, Interlochen
Affinity Healthcare, Arlington Heights
Women's Clinic of Lincoln, PC, Lincoln
NEA Baptist Women's Clinic, Jonesboro
Sooner Clinical Research, Inc., Oklahoma City
Advances In Health, Inc., Houston
The Woman's Hospital of Texas Clinical Research Center, Houston
Research Across America, Katy
DiscoveResearch, Inc., Bryan
Clinical Trials of Texas, Inc., San Antonio
Radiant Research, Inc., San Antonio
Tekton Research, Austin
Downtown Women's Health Care, Denver
Horizons Clinical Research Center, LLC, Denver
The Women's Clinic of Northern Colorado, Fort Collins
Advanced Clinical Research, Boise
East Valley Family Physicians PLC, Chandler
Advanced Research Associates, Glendale
Premier Research Group Limited, Peoria
Verona Clinical Research, Inc, Tucson
Albuquerque Clinical Trials, Albuquerque
New Mexico Clinical Research & Osteoporosis Center, Inc., Albuquerque
Clinical Research Center of Nevada, Las Vegas
Facey Medical Foundation, Mission Hills
Grossmont Center for Clinical Research, La Mesa
University Clinical Research, San Diego
Medical Center for Clinical Research, San Diego
Apex Research Institute, Santa Ana
High Desert Medical Group, Lancaster
Northern California Research, Sacramento
Women's Clinical Research Center, Seattle
North Spokane Women's Clinic Research, Spokane
Danbury Clinical Research, LLC, Danbury
Coastal Connecticut Research, LLC, New London
Beacon Clinical Research, LLC, Brockton
Neurocare Center for Research, Newton
Lawrence Ob-Gyn Assoc., PC, Lawrenceville
Partners in Clinical Research, Cumberland
Lead Sponsor
Noven Therapeutics
INDUSTRY